Andrographolide presents therapeutic effect on ulcerative colitis through the inhibition of IL-23/IL-17 axis.
In conclusion, we demonstrated that andrographolide inhibited the activity of IL-23/IL-17 axis and down-stream pro-inflammatory factors so as to suppress inflammation response, resulting in the relieving of UC.
PMID: 29511440 [PubMed]
Source: American Journal of Translational Research - Category: Research Tags: Am J Transl Res Source Type: research
More News: Cancer | Cancer & Oncology | Colon Cancer | Colorectal Cancer | Inflammatory Bowel Disease | Research | Study | Ulcerative Colitis